Featured Research

from universities, journals, and other organizations

Scientists Induce A Form Of Leukemia In Mice, Gaining An Unprecedented Glimpse Into The Disorder's Roots

Date:
November 17, 1998
Source:
Brandeis University
Summary:
In a finding that promises to expand greatly the scope of leukemia research, scientists at Brandeis University have induced a form of the disease in mice that's strikingly similar to chronic myelogenous leukemia (CML), which affects humans.

WALTHAM, Mass. -- In a finding that promises to expand greatly the scope of leukemia research, scientists at Brandeis University have induced a form of the disease in mice that's strikingly similar to chronic myelogenous leukemia (CML), which affects humans. The development gives researchers their best opportunity yet to probe CML's molecular origins, tracing it from a simple mutation involving two genes into a disease that accounts for fully one-fifth of all leukemia patients.

Ruibao Ren, assistant professor of biology in Brandeis' Rosenstiel Basic Medical Sciences Research Center, and Xiaowu Zhang, a graduate student in biochemistry, have accomplished what a host of leukemia researchers have been striving toward for years: essentially using gene therapy in reverse, they incorporated a leukemia-inducing gene into a mouse's genome with the help of a retrovirus. The work, sponsored by the National Cancer Institute and the American Cancer Society, appears in the Nov. 15 issue of the journal "Blood"; a second group from the University of Pennsylvania reports similar findings in the same issue.

Scientists understand the basics of how CML arises: in a single marrow cell, the genes bcr and abl, usually found on separate chromosomes, brush up against each other and fuse into a new gene called bcr-abl. This entity is a known oncogene, a genetic precursor to cancer. How the disease mushrooms from this isolated genetic flaw in just one of the body's trillion cells into a widespread cancer of the body's white blood cells remains a mystery, though.

"Owing to their medical importance, CML's molecular mechanisms have long been the subject of intense study," Ren says. "But there's a lot we have yet to learn about the pathways by which it and other leukemias arise."

For a decade, scientists' primary avenues of CML research have been the study of tumor cells removed from CML patients and the study of inserted oncogenes' effects on animal cells growing in petri dishes. However, these approaches can't do justice to the complexity of a disease that eventually affects blood cells throughout the body. With the development of the first effective and efficient animal models of CML, Ren's group has succeeded in laying the genetic bedrock for the disease -- meaning they can now observe the disorder's progress from its earliest stages, looking for the weak link in the process that might be vulnerable to drugs.

A number of other scientists have taken approaches more similar to Ren's over the last decade, splicing leukemia genes into the mouse genome. But these previous attempts worked very slowly when they worked at all; often months or even years elapsed between the insertion of a gene and the development of leukemia in a mouse, hobbling research projects. For as-yet unknown reasons, Ren's tactic works much more efficiently and predictably.

After preliminary work with the mouse model, Ren suspects the bcr-abl oncogene may induce leukemia by spurring production of growth factors that cancerous cells need in order to survive. He's now examining whether strains of mice that are genetically incapable of producing these growth factors remain healthy even in the presence of an inserted bcr-abl oncogene.

"Since cancerous cells need certain growth factors, it's possible that targeting them may hold the key to controlling CML," Ren says. "We probably won't be able to prevent the disease from arising, but we may be able to use these growth factors to nip it in the bud."

The only treatments now available for leukemia are bone marrow transplants and chemotherapy, neither of which are viable options for many sicker patients. Through their studies with mice, Ren and his colleagues hope to identify potential new leukemia therapies.


Story Source:

The above story is based on materials provided by Brandeis University. Note: Materials may be edited for content and length.


Cite This Page:

Brandeis University. "Scientists Induce A Form Of Leukemia In Mice, Gaining An Unprecedented Glimpse Into The Disorder's Roots." ScienceDaily. ScienceDaily, 17 November 1998. <www.sciencedaily.com/releases/1998/11/981117080225.htm>.
Brandeis University. (1998, November 17). Scientists Induce A Form Of Leukemia In Mice, Gaining An Unprecedented Glimpse Into The Disorder's Roots. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/1998/11/981117080225.htm
Brandeis University. "Scientists Induce A Form Of Leukemia In Mice, Gaining An Unprecedented Glimpse Into The Disorder's Roots." ScienceDaily. www.sciencedaily.com/releases/1998/11/981117080225.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins